Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Return on Sales [ROS] (2012 - 2026)

Updated

Grace Therapeutics (GRCE) recorded Return on Sales [ROS] of -11288.65% in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 9773.95 percentage points from -1514.71% a year earlier and down 9107.49 percentage points from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Return on Sales [ROS] (2012 - 2026) Analysis & Trends

On a TTM basis, Grace Therapeutics' Return on Sales [ROS] came in at -3837.08% as of Jun 30, 2026, down 1712.54 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it was -1617.08%, up 673.99 percentage points from FY2025.

  • Annual Return on Sales [ROS] has a five-year change of +6759.96 percentage points (FY2021 to FY2026).
  • Across earlier fiscal years, Return on Sales [ROS] came in at -2291.07% in FY2025 (-822.27 pp) and -1468.80% in FY2024.
  • The fiscal Q1 2027 figure is the lowest quarterly Return on Sales [ROS] since fiscal Q3 2016.
  • On a year-over-year basis, Return on Sales [ROS] rose in three of the last five quarters, with an average year-over-year change of -1390.25 percentage points.
  • Per Business Quant, the preceding three fiscal quarters came in at -2181.16% (Q4 2026), -1423.84% (Q3 2026) and -1470.35% (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 24.35%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 36.01%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 30.74%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 29.12%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 35.79%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 41.71%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 32.98%
10 Grace Therapeutics 35.10 Mn -35.61 Mn - -1,488.31%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11,288.65%
Mar 31, 2026 -2,181.16%
Dec 31, 2025 -1,423.84%
Sep 30, 2025 -1,470.35%
Jun 30, 2025 -1,514.71%
Mar 31, 2025 -1,729.89%
Dec 31, 2024 -2,916.54%
Sep 30, 2024 -2,654.40%
Jun 30, 2024 -2,111.91%
Mar 31, 2022 -7,953.57%
Dec 31, 2021 -987.12%
Mar 31, 2021 -2,000.00%
Dec 31, 2020 -2,424.69%
Mar 31, 2018 -0.43%
Dec 31, 2017 -4,377.04%
Sep 30, 2017 -846.22%
Nov 30, 2016 -199.71%
Aug 31, 2016 -44,508.35%
May 31, 2016 -79,155.12%
Nov 30, 2015 -39,180.13%
API Access

Grace Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=GRCE&period=max&api_key=YOUR_API_KEY